Beril Altun

Dr. Beril Altun


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
BABeril Altun
Beril Altun
IÇİsmet Çok
İsmet Çok
Synthetic cathinones are new designer drugs that possess hallucinogenic and psychostimulant properties, and are designed to mimic the effects of illegal substances such as cocaine, amphetamines, and 3.4-methylenedioxymethamphetamine (ecstasy) and to produce rewarding effects, circumventing existing laws and penalties. Synthetic cathinones, also referred to as 'bath salts', have become popular particularly among young people since the mid-2000s. Similar to other psychomotor stimulants, synthetic cathinones have the potential to increase monoamine concentration in the synaptic cleft by targeting the plasma membrane transporters of dopamine, norepinephrine, and serotonin. Because of their structural similarities to amphetamines, it has been suggested that synthetic cathinones may have a neurotoxicity profile similar to that of their amphetamine congeners. Therefore, it has been hypothesized that synthetic cathinones may induce neurotoxicity on monoamine nerve endings in the striatum, hippocampus, and cortex. To date, with regard to synthetic cathinone neurotoxicity, parameters such as monoamine depletion, biosynthetic enzyme inhibition, cytotoxicity, generation of reactive oxygen species, pro-oxidation status, and the ability to induce neuroinflammation were investigated in both in vitro and in vivo experimental studies. Compared with amphetamines, synthetic cathinones appear to have more moderate effects than their amphetamine congeners in terms of neurotoxic effects. However, many synthetic cathinone users take these substances simultaneously with other substances such as benzodiazepines, amphetamines, ecstasy, tetrahydrocannabinol, and ethanol and this abuse can modify their neurotoxic effects. Hence, it is important to understand the underlying mechanism of early neurotoxic effects in case of polysubstance use. In this review, we aimed to present up-to-date information on the abuse potential of synthetic cathinones, their legal status, mechanism of action, and particularly their neurotoxic effects.

1 December 2020 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
DFDolunay Merve Fakioğlu
Dolunay Merve Fakioğlu
BABeril Altun
Beril Altun
Cystic fibrosis (CF) is a hereditary, multisystemic disease caused by different mutations in the CFTR gene encoding CF transmembrane conductance regulator. CF is mainly characterized by pulmonary dysfunction as a result of deterioration in the mucociliary clearance and anion transport of airways. Mortality is mostly caused by bronchiectasis, bronchiole obstruction, and progressive respiratory dysfunction in the early years of life. Over the last decade, new therapeutic strategies rather than symptomatic treatment have been proposed, such as the small molecule approach, ion channel therapy, and pulmonary gene therapy. Due to considerable progress in the treatment options, CF has become an adult disease rather than a pediatric disease in recent years. Pulmonary gene therapy has gained special attention due to its mutation type independent aspect, therefore being applicable to all CF patients. On the other hand, the major obstacle for CF treatment is to predict the drug response of patients due to genetic complexity and heterogeneity. The advancement of 3D culture systems has made it possible to extrapolate the disease modeling and individual drug response in vitro by producing mini adult organs called "organoids" obtained from rectal cell biopsies. In this review, we summarize the advances in the novel therapeutic approaches, clinical interventions, and precision medicine concept for CF.

19 September 2018 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
EKEla Kadioglu
Ela Kadioglu
BABeril Altun
Beril Altun
ÇIÇağrı İpEk
Çağrı İpEk
EDEsra Döğer
Esra Döğer
ABAysun Bideci
Aysun Bideci
IÇİsMet Çok
İsMet Çok

22 May 2025 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
BABeril Altun
Beril Altun
ICİsMet Cok
İsMet Cok
CNCemal Onur Noyan
Cemal Onur Noyan
EKEla Kadioglu
Ela Kadioglu
ACAlptekin Cetin
Alptekin Cetin
HDHilmiye Nesrin Dilbaz
Hilmiye Nesrin Dilbaz
Objectives: Obesity is a global health problem related to reduced life quality and shorter life expectancy. Given the fact that genetic factors play a role in obesity development, studies have suggested that polymorphisms of cannabinoid receptor 1 ( CNR1 ), monoacylglycerol lipase ( MGLL ), and fatty acid amide hydrolase ( FAAH ) genes located in the endocannabinoid system (ECS) are related to overweight/obesity risk. Accordingly, we aimed to assess the genetic susceptibility to overweight/obesity in individuals with Turkish ancestral origin concerning these ECS genes. Methods: The present study comprised 194 unrelated individuals with Turkish ancestral origin living in the Marmara Region. The study population is categorized into two groups according to their body mass index (BMI) overweight/obese group (BMI≥25) and normal weight group (18.5<BMI<25). Genotyping of the CNR1 rs1049353 , MGLL rs60430 , and FAAH rs324420 polymorphisms was performed using the real-time polymerase chain reaction (RT-PCR). Results: The GG genotype frequency of CNR1 rs1049353 was significantly higher in overweight/obese individuals than in normal weight individuals (75.5 vs. 61.4 %, respectively; p=0.034). No difference was observed in terms of MGLL rs604300 and FAAH rs324420 polymorphisms between the groups (p>0.05). The genotype distributions of CNR1 , MGLL , and FAAH genes were compatible with the Hardy–Weinberg equilibrium (p>0.05). Conclusions: Our findings supported that individuals with AA/AG genotype of CNR1 rs1049353 have reduced overweight/obesity risk; however, neither FAAH rs324420 nor MGLL rs604300 showed any association. A relatively smaller sample size and lack of inclusion of obesity-related measurements could be considered the limitations of this study. Further research is needed to confirm or disprove our results.

16 April 2024
Verified
Book
Open access
PDF file
SSSaja Said
Saja Said
GÖGül Özbey
Gül Özbey
BABeril Altun
Beril Altun
NDNurcan DEDEOĞLU
Nurcan DEDEOĞLU
MSMehtap Tugrak Sakarya
Mehtap Tugrak Sakarya
BKBerna Öztürk Karagöz
Berna Öztürk Karagöz
Pharmacogenetics of Antidepressants: Overview of Dosing Strategies in Major Depressive Disorder Saja SAİD Gül ÖZBEY Therapeutic Use of Cannabinoids: Clinical Overview and Recent Updates Beril ALTUN The Xanthine Oxidase Inhibitory Activities of Natural-Based Compounds Targeting Gout Nurcan DEDEOĞLU The Relationship of Dementia and Diabetes Mehtap TUGRAK SAKARYA Rational Use of Drugs Dilan ÖZMEN ÖZGÜN Endocrine Therapy in Breast Cancer: Recent Advances in the Drugs Used Dilek AKSOY Strategies to Increase Solubility and Bioavailability of Drugs İrem ÇİNAR Emrah ÖZAKAR Rukiye SEVİNÇ ÖZAKAR Vesıcular Drug Delivery Systems Muhammet Enes ÖZMUTLU Rukiye SEVİNÇ ÖZAKAR Emrah ÖZAKAR Definition of Pharmacovigilance and Its Historical Development in the World and Türkiye Berna ÖZTÜRK KARAGÖZ

8 May 2023 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
BABeril Altun
Beril Altun
ICIsmet Cok
Ismet Cok
CNCemal Onur Noyan
Cemal Onur Noyan
EKEla Kadioglu
Ela Kadioglu
ACAlptekin Cetin
Alptekin Cetin
HDHilmiye Nesrin Dilbaz
Hilmiye Nesrin Dilbaz
Objectives: Given that drug addiction occurs as a result of complex gene-environment interaction, a number of studies claimed that cannabinoid receptor 1 ( CNR1 ), fatty acid amide hydrolase ( FAAH ), and monoacylglycerol lipase ( MGLL ) single nucleotide polymorphisms (SNPs) are associated with the risk of substance use disorders such as cannabis, opioids, and, methamphetamine. However, scientific research on genetic susceptibility to synthetic cannabinoid addiction is limited. In this population-based case-control study, we aimed to evaluate the genetic susceptibility to synthetic cannabinoid use disorder in terms of these three endocannabinoid system genes in the Turkish population. Methods: 100 individuals diagnosed with synthetic cannabinoid use disorder according to Diagnostics and Statistical Manual of Mental Disorders-5 criteria and 100 healthy volunteers have recruited for the study. Genotyping of the CNR1 rs1049353 , FAAH rs324420 , and MGLL rs604300 SNPs was performed using Real-Time Polymerase Chain Reaction hybridization probes. Results: The patient and control groups consist of 98 % male, 2 % female, 80 % male, and 20 % female individuals, respectively. The genotype distributions were consistent with Hardy–Weinberg equilibrium for all SNPs (p>0.05). FAAH rs324420 and MGLL 604300 SNPs were genotyped for the first time in the Turkish population, and the variant allele frequencies were found as 0.205 and 0.085, respectively. Allele frequencies and genotype distributions CNR1 rs1049353 , FAAH rs324420 , and MGLL rs604300 SNPs were similar between the patient and control group (p>0.05). Conclusions: These results indicate that CNR1 , FAAH , and MGLL gene polymorphisms do not influence the risk of synthetic cannabinoid use disorder in the Turkish population.